Tectonic Therapeutic Inc Live Stock Price Today, Share Analysis and Chart

Name: Tectonic Therapeutic Inc.: Is Infosys Ltd. worth buying?
Item: Tectonic Therapeutic Inc.
Rating: 1.80358325
Author: Trendlyne DVM scores

about

Avrobio Inc is a clinical-stage gene therapy company. The company is engaged in developing potentially curative ex vivo lentiviral gene therapies to treat rare diseases following a single-dose treatment regimen. The company's pipeline includes AVR-RD...

27.89 -1.91 (-6.41%)

93.95% Gain from 52W Low

298.1K

XNAS Volume

XNAS 15 May, 2026 5:30 PM (EDT)

Not Eligible

Expensive Valuation

9.8 / 100

Technically Moderately Bullish

62.3 / 100

No estimates available

Tectonic Therapeutic Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Tectonic Therapeutic Inc Live Stock Price Today, Share Analysis and Chart

Avrobio Inc is a clinical-stage gene therapy company. The company is engaged in developing potentially curative ex vivo lentiviral gene therapies to treat rare diseases following a single-dose treatment regimen. The company's pipeline includes AVR-RD...

93.95% Gain from 52W Low

SWOT Analysis

Tectonic Therapeutic Inc Live Price Chart